↓ Skip to main content

Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand

Overview of attention for article published in Journal of Hematology & Oncology, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news
2 news outlets
twitter
2 X users
patent
2 patents

Citations

dimensions_citation
98 Dimensions

Readers on

mendeley
151 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand
Published in
Journal of Hematology & Oncology, April 2019
DOI 10.1186/s13045-019-0733-6
Pubmed ID
Authors

Lin Mei, Junran Zhang, Kai He, Jingsong Zhang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 151 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 15%
Student > Ph. D. Student 17 11%
Student > Master 17 11%
Researcher 16 11%
Student > Doctoral Student 5 3%
Other 15 10%
Unknown 58 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 45 30%
Medicine and Dentistry 12 8%
Agricultural and Biological Sciences 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Chemistry 4 3%
Other 15 10%
Unknown 61 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 May 2022.
All research outputs
#1,515,661
of 23,146,350 outputs
Outputs from Journal of Hematology & Oncology
#81
of 1,202 outputs
Outputs of similar age
#36,141
of 350,145 outputs
Outputs of similar age from Journal of Hematology & Oncology
#6
of 24 outputs
Altmetric has tracked 23,146,350 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,202 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 350,145 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.